Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Natural Excipient Development:Need and Future


Affiliations
1 Columbia Institute of Pharmacy, Vill. Tekari, Near Vidhan Sabha, Raipur (C.G), India
2 Bengal School of Technology, Sugandha, Delhi Road, Hooghly (W.B), India
3 GRY Institute of Pharmacy, Vidya Vihar, Borawan, Khargone (M.P), India
     

   Subscribe/Renew Journal


The objective of any formulation is to deliver drug to the patient in the definite amount, at the required rate, and maintains the stability of drug over the product's shelf life. To produce a drug formulation in a final dosage form, a number of pharmaceutical ingredients are required. In selecting excipients for pharmaceutical dosage forms and drug products the development pharmacist should be certain about the existing standards and safety parameters of the excipients. This will assure the consistent quality and functioning of the excipient. The selection and testing of non active ingredients or excipient in the design of drug dosage form present to the formulator the challenge of predictive foresight. While the ability to solve problems when they occur is a valuable attribute, the ability to prevent the problem through adequate experimental design is a virtue. The safety and biodegradability issues related to synthetic excipients have necessitates development of new natural excipients. Newer excipients provide the means for simplifying formulation development, and improving overall operational costs while preserving the quality that is expected by the industry. This review focuses on need to develop such newer natural excipients which shall be utilized to develop efficient dosage forms and the economics involved in doing so.
Subscription Login to verify subscription
User
Notifications
Font Size


Abstract Views: 230

PDF Views: 1




  • Natural Excipient Development:Need and Future

Abstract Views: 230  |  PDF Views: 1

Authors

Sanjib Bahadur
Columbia Institute of Pharmacy, Vill. Tekari, Near Vidhan Sabha, Raipur (C.G), India
Amit Roy
Columbia Institute of Pharmacy, Vill. Tekari, Near Vidhan Sabha, Raipur (C.G), India
Ranabir Chanda
Bengal School of Technology, Sugandha, Delhi Road, Hooghly (W.B), India
Ananta Choudhury
Columbia Institute of Pharmacy, Vill. Tekari, Near Vidhan Sabha, Raipur (C.G), India
Sujoy Das
GRY Institute of Pharmacy, Vidya Vihar, Borawan, Khargone (M.P), India
Suman Saha
Columbia Institute of Pharmacy, Vill. Tekari, Near Vidhan Sabha, Raipur (C.G), India
Shashikant Chandrakar
Columbia Institute of Pharmacy, Vill. Tekari, Near Vidhan Sabha, Raipur (C.G), India
Pushpa Prasad
Columbia Institute of Pharmacy, Vill. Tekari, Near Vidhan Sabha, Raipur (C.G), India

Abstract


The objective of any formulation is to deliver drug to the patient in the definite amount, at the required rate, and maintains the stability of drug over the product's shelf life. To produce a drug formulation in a final dosage form, a number of pharmaceutical ingredients are required. In selecting excipients for pharmaceutical dosage forms and drug products the development pharmacist should be certain about the existing standards and safety parameters of the excipients. This will assure the consistent quality and functioning of the excipient. The selection and testing of non active ingredients or excipient in the design of drug dosage form present to the formulator the challenge of predictive foresight. While the ability to solve problems when they occur is a valuable attribute, the ability to prevent the problem through adequate experimental design is a virtue. The safety and biodegradability issues related to synthetic excipients have necessitates development of new natural excipients. Newer excipients provide the means for simplifying formulation development, and improving overall operational costs while preserving the quality that is expected by the industry. This review focuses on need to develop such newer natural excipients which shall be utilized to develop efficient dosage forms and the economics involved in doing so.